Pitfalls in scintigraphic detection of neuroendocrine tumours
- 1 March 1992
- journal article
- case report
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 19 (3) , 214-218
- https://doi.org/10.1007/bf00173284
Abstract
We report 4 cases of abnormal results using iodine-123 metaiodobenzylguanidine (123I-mIBG) or technetium-99m (V) dimercaptosuccinic acid (99mTc(V)-DMSA) scintigraphy in the diagnosis and follow-up of presumed neuroendocrine tumours. The present series consisted of 2 false-positive cases (1 adenomatous polyp of the caecum with mIBG and 1 follicular adenoma of the thyroid with DMSA) and 2 cases of anomalous uptake of (V)-DMSA in a non-neuroendocrine tissue.Keywords
This publication has 11 references indexed in Scilit:
- Radioiodinated metaiodobenzylguanidine (*I-MIBG) scintigraphy in neuroblastoma: a review of 160 studies.1990
- Analogy between Tumor Uptake of Technetium(V)-99m Dimercaptosuccinic Acid (DMSA) and Technetium-99m-MDPClinical Nuclear Medicine, 1989
- Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.1988
- PENTAVALENT [TC-99M]DMSA, [I-131]MIBG, AND [TC-99M]MDP-AN EVALUATION OF 3 IMAGING TECHNIQUES IN PATIENTS WITH MEDULLARY CARCINOMA OF THE THYROID1988
- Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.1987
- RADIONUCLIDE DIAGNOSIS AND THERAPY OF NEURAL CREST TUMORS USING I-131 METAIODOBENZYLGUANIDINE1987
- Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.1986
- IMAGING OF MEDULLARY THYROID CANCER WITH 131I-MIBGThe Lancet, 1984
- A new imaging agent for medullary carcinoma of the thyroid.1984
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981